Krsnaa DiagnosticsNSE:KRSNAA -1.75%71 Interest Coverage is 2.67 as of Mar. 2026, which is 30% below its 10-year median of 3.83. GuruFocus rates NSE:KRSNAA with a GF Score™ of 71/100 and a GF Value™ of ₹901.24 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 94 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks worse than 79.79% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Krsnaa Diagnostics's
Operating Income
for the
three
months ended in Mar. 2026 was ₹323 Mil. Krsnaa Diagnostics's Interest Expense for the
three
months ended in Mar. 2026 was ₹-121 Mil.
Krsnaa Diagnostics's interest coverage for the quarter that ended in Mar. 2026 was 2.67.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Krsnaa Diagnostics's Interest Coverage or its related term are showing as below:
NSE:KRSNAA'
s Interest Coverage Range Over the Past 10 Years
Min: 1.31 Med: 3.83 Max: 10.76
Current: 3.53
NSE:KRSNAA's Interest Coverage is ranked worse than 79.79% of 94
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.155
vs NSE:KRSNAA: 3.53
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Krsnaa Diagnostics Interest Coverage Related Terms
Krsnaa Diagnostics Interest Coverage Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:KRSNAA vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krsnaa Diagnostics (NSE:KRSNAA) has a Interest Coverage of 2.67 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Krsnaa Diagnostics and its competitors. This is 30% below median its historical median of 3.83. Over the past decade, Krsnaa Diagnostics' Interest Coverage has ranged from 1.31 to 10.76. According to the industry distribution chart, Krsnaa Diagnostics ranks #75 out of 94 companies in the Medical Diagnostics & Research industry, placing it in the top 79.8%.
Is Krsnaa Diagnostics' Interest Coverage too high?
Krsnaa Diagnostics' current Interest Coverage of 2.67 is 30% below median its 10-year median of 3.83. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 10.76. The Medical Diagnostics & Research industry median Interest Coverage is 9.16. Krsnaa Diagnostics' value of 2.67 is 70.8% below this industry median. Based on the distribution chart, Krsnaa Diagnostics ranks #75 out of 94 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #75 out of 94 companies for Interest Coverage. This places Krsnaa Diagnostics in the lower half of its industry. The industry median Interest Coverage is 9.16. Krsnaa Diagnostics' value of 2.67 is 70.8% below this benchmark. Historically, Krsnaa Diagnostics' own Interest Coverage has ranged from 1.31 to 10.76 over the past decade. While the company's 10-year median is 3.83 vs. the industry median of 9.16, Krsnaa Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.16, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krsnaa Diagnostics's current Interest Coverage of 2.67 is 70.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current Interest Coverage is 2.67, which is 30% below median its own 10-year median of 3.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹901.24, compared to a current price of ₹562.85 — trading 37.5% below its estimated fair value. The current Interest Coverage is 2.67, which is 30% below median its 10-year median of 3.83 and 70.8% below the Medical Diagnostics & Research industry median of 9.16. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Interest Coverage is 2.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹562.85 is trading 37.5% below its estimated GF Value™ of ₹901.24.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
Interest Coverage: 2.67 (30% below median its 10-year median of 3.83)
GF Value™: ₹901.24 vs. price of ₹562.85 (37.5% below fair value)
Industry Position: 70.8% below the Medical Diagnostics & Research median (#75 of 94)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score
Get the complete analysis for NSE:KRSNAA
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
